Background: Congenital adrenal hyperplasia in females leads to virilization of external genitalia and persistent urogenital sinus. There are controversies regarding the timing and outcomes of surgery. Deferring surgeries beyond childhood is difficult to implement in conservative societies, and may result in stigmatization and distress to individuals with disorders of sexual differentiation and their families. Methods: Thirty girls with virilization due to congenital adrenal hyperplasia were admitted for single-stage feminizing genitoplasty, between 2011 and 2014. We prospectively studied the concerns and input of the families represented by the mothers. After comprehensive counselling, the mothers completed a questionnaire to clarify their priorities and concerns related to surgery. Results: Surgeries were performed at a mean age of 22 months. Most cases ranged between Prader's degrees III and IV. Egyptian families believe that early surgical reconstruction is in the best interest of their girls. They are marginally more concerned about functional outcomes and future child bearing than external appearance and cosmetic outcomes. Conclusions: Social difficulties noticeably add challenges to the management plan within conservative societies. Early genital reconstructive surgery, when reasonably indicated, needs to remain a viable option. Comprehensive psychosocial support within a multidisciplinary approach is needed to defer feminizing genitoplasty in selected cases to adolescence.

1.
Marei M, Fares A, Abdelsattar A, Hassan M, El-Kotby M, El-Barbary M: Evaluation of early outcomes of feminizing genitoplasty in virilised female children with congenital adrenal hyperplasia. Kasr El Aini Med J 2014;20:7-27.
2.
Marei M, Abdelsattar A, Fares A, El-Kotby M, El-Barbary M, Seif H: Accuracy and predictivity of cystoscopy and genitography to operative findings in persistent urogenital sinus due to virilized female congenital adrenal hyperplasia. Kasr El Aini J Surg 2014;15:21-25.
3.
New MI: Diagnosis and management of congenital adrenal hyperplasia. Annu Rev Med 1998;49:311-328.
4.
Donahoe PK, Schnitzer JJ: Evaluation of the infant who has ambiguous genitalia, and principles of operative management. Semin Pediatr Surg 1996;5:30-40.
5.
Hendren WH, Crawford JD: Adrenogenital syndrome: the anatomy of the anomaly and its repair. Some new concepts. J Pediatr Surg 1969;4:49-58.
6.
Hendren H, Atala A: Repair of the high vagina in girls with severely masculinized anatomy from the adrenogenital syndrome. J Pediatr Surg 1995;30:91-94.
7.
Leslie JA, Rink RC: Feminizing genitoplasty and correction of cloacal anomalies; in Montague DK, Gill IS, Angermeier KW, Ross JH (eds): Textbook of Reconstructive Urologic Surgery. Boca Raton, CRC Press, 2008, vol 73, pp 599-611.
8.
Dasgupta R, Schnitzer JJ, Hendren WH, Donahoe PK: Congenital adrenal hyperplasia: surgical considerations required to repair a 46,XX patient raised as a male. J Pediatr Surg 2003;38:1269-1273.
9.
Schober JM: Feminization (surgical aspects); in Stringer M, Oldham K, Mouriquand P (eds): Pediatric Surgery and Urology: Long-Term Outcomes, ed 2. Cambridge, Cambridge University Press, 2008, vol 46, pp 595-610.
10.
Callens N, Van der Zwan YG, Drop S, Cools M, Beerendonk CM, Wolffenbuttel KP, Dessens AB: Do surgical interventions influence psychosexual and cosmetic outcomes in women with disorders of sex development? ISRN Endocrinol, Epub ahead of print.
11.
Savanelli A, Alicchio F, Esposito C, De Marco M, Settimi A: A modified approach for feminizing genitoplasty. World J Urol 2008;26:517-520.
12.
Rink RC, Adams MC: Feminizing genitoplasty state of the art. World J Urol 1998;16:212-218.
13.
Freitas Filho LG, Carnevale J, Melo CE, Laks M, Calcagno Silva MA: A posterior-based omega-shaped flap vaginoplasty in girls with congenital adrenal hyperplasia caused by 21-hydroxylase deficiency. BJU Int 2003;91:263-267.
14.
Passerini-Glazel G: Feminizing genitoplasty. J Urol 1999;161:1592-1593.
15.
Jenak H, Ludwikowski B, Gonzalez R: Total urogenital sinus mobilization: a modified perineal approach for feminizing genitoplasty and urogenital sinus repair. J Urol 2001;165:2347-2349.
16.
Rink RC, Metcalfe PD, Casale AJ, Cain MP, Meldrum KK, Kaefer MA: Partial urogenital mobilization: a limited proximal dissection. J Pediatr Urol 2006;2:351-356.
17.
Palmer BW, Trojan B, Griffin K, Reiner W, Wisniewski A, Frimberger D, et al: Total and partial urogenital mobilization: focus on urinary continence. J Urol 2012;187:1422-1426.
18.
Podesta M, Urcullo J: Partial mobilization of the common UGS for surgical correction of high urethrovaginal confluence in patients with intersex disorders. J Pediatr Urol 2008;4:352-358.
19.
Schober JM: Long-term outcomes and changing attitudes to intersexuality. BJU Int 1999;83:39-50.
20.
Speiser PW, Azziz R, Baskin LS, Ghizzoni L, Hensle TW, Merke DP, et al: Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2010;95:4133-4160.
21.
Bronselaer G, Callens N, De Sutter P, De Cuypere G, T'Sjoen G, Cools M, Hoebeke P: Self-assessment of genital anatomy and sexual function in women (SAGAS-F): validation within a Belgian, Dutch-speaking population. J Sex Med 2013;10:3006-3018.
22.
Kohler B, Kleinemeier E, Lux A, Hiort O, Gruters A, Thyen U; DSD Network Working Group: Satisfaction with genital surgery and sexual life of adults with XY disorders of sex development: results from the German clinical evaluation study. J Clin Endocrinol Metab 2012;97:577-588.
23.
Creighton S, Minto C, Steele S: Objective cosmetic and anatomical outcomes at adolescence of feminizing surgery for ambiguous genitalia done in childhood. Lancet 2001;358:124-125.
24.
Minto CL, Liao LM, Woodhouse CR, Ransley PG, Creighton SM: The effect of clitoral surgery on sexual outcome in individuals who have intersex conditions with ambiguous genitalia: a cross-sectional study. Lancet 2003;361:1252-1257.
25.
Creighton S: Long-term sequelae of genital surgery; in Balen A, Creighton S, Davies MC, MacDougall J, Stanhope R (eds): Paediatric and Adolescent Gynaecology: A Multidisciplinary Approach. Cambridge, Cambridge University Press, 2004, pp 327-333.
26.
Preves SE: For the sake of the children: destigmatizing intersexuality. J Clin Ethics 1998;9:411-420.
27.
Pippi Salle JL: Corporeal sparing dismembered clitoroplasty: an alternative technique for feminizing genitoplasty. J Urol 2007;178:1796-1801.
28.
Egypt Demographic and Health Survey 2014. Ministry of Health and Population, Cairo. El-Zanaty and Associates, Cairo. The DHS Program, ICF International, Rockville.
29.
The World Bank. Data by Country/Egypt, Arab Rep. http://data.worldbank.org/country/egypt-arab-republic (accessed October 15, 2015).
30.
The Holy Quran. An-Najm (The Star) 53:45-46. Al-Hujurat (The Chambers) 49:13. Ash-Shura (The Consultation) 42:49.
31.
Sabiq El-Sayed (ed): Inheritance of intersex/hermaphrodite; in: Fiqh Al-Sunnah, ed 5. Dar Al-Fikr 1971, Part 3, p 454.
32.
Hughes IA, Houk C, Ahmed SF, Lee PA: Consensus statement on management of intersex disorders. J Pediatr Urol 2006;2:148-162.
33.
Houk C, Hughes IA, Ahmed SF, Lee PA: Summary of consensus statement on intersex disorders and their management. International Intersex Consensus Conference. Pediatrics 2006;118:753-757.
34.
Wisniewski AB, Migeon CJ, Malouf MA, Gearhart JP: Psychosexual outcome in women affected by congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Urol 2004;171:2497-2501.
35.
Fedele DA, Kirk K, Wolfe-Christensen C, Phillips TM, Mazur T, Mullins LL, et al: Primary caregivers of children affected by disorders of sex development: mental health and caregiver characteristics in the context of genital ambiguity and genitoplasty. Int J Pediatr Endocrinol 2010;2010:690674.
36.
Nordenström A, Frisén L, Falhammar H, Filipsson H, Holmdahl G, Janson O, et al: Sexual function and surgical outcome in women with congenital adrenal hyperplasia due to CYP21A2 deficiency: clinical perspective and the patients' perception. J Clin Endocrinol Metab 2010;95:3633-3640.
37.
Warne GL, Grover S, Hutson J, Sinclair A, Metcalfe S, Northam E, et al: A long-term outcome study of intersex conditions. J Pediatr Endocrinol Metab 2005;18:555-567.
38.
Warne GL: Management of ambiguous genitalia at birth; in Balen A, Creighton S, Davies MC, MacDougall J, Stanhope R (eds): Paediatric and Adolescent Gynaecology: A Multidisciplinary Approach. Cambridge, Cambridge University Press, 2004, pp 97-103.
39.
Azziz R, Mulaikal RM, Migeon CJ: Congenital adrenal hyperplasia: long-term results following vaginal reconstruction. Fertil Steril 1986;46:1011-1014.
40.
Alizai NK, Thomas DFM, Lilford RJ, Batchelor AGG, Johnson N: Feminizing genitoplasty for congenital adrenal hyperplasia: what happens at puberty? J Urol 1999;161:1588-1591.
41.
Vates TS, Fleming P, Leleszi JP, et al: Functional, social and psychosexual adjustment after vaginal reconstruction. J Urol 1999;162:182-187.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.